Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06854978 · ClinicalTrials.gov registry record · NA

R3THA Rehabilitation Feasibility and Usability Study

A NA study of Stroke, sponsored by Kessler Foundation.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT06854978: Recruiting NA study of Stroke, sponsored by Kessler Foundation.

NCT06854978 is a NA study of Stroke that is actively recruiting participants, run by Kessler Foundation. The registered enrollment target is 10 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06854978, a NA study of Stroke, is actively recruiting participants, sponsored by Kessler Foundation.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess how the Rehabilitation Technologies for Hand and Arm (R3THA) device can be used for rehabilitation of people with stroke. the study will evaluate the feasibility of R3THA as outpatient telerehabilitation administered by trained clinicians to individuals with stroke.

Primary Outcome

System Usability Scale is a well-established standardized metric used to measure usability perception of computer interfaces and products.

Conditions Studied

Interventions

  • OTHER RETHA

Study Locations (1)

New Jersey

  • Kessler Foundation - West Orange

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2024-03-27
Est. Completion 2026-03-25
Phase NA
Kessler Foundation

104 total trials

What NCT06854978 shows while recruiting

NCT06854978 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which RETHA is the first listed.

NCT06854978 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT06854978 about?

NCT06854978 is a clinical study titled "R3THA Rehabilitation Feasibility and Usability Study". The purpose of this study is to assess how the Rehabilitation Technologies for Hand and Arm (R3THA) device can be used for rehabilitation of people with stroke. the study will evaluate the feasibility of R3THA as outpatient telerehabilitation administered by trained clinicians to individuals with st...

What is the current status of trial NCT06854978?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2024-03-27. Estimated completion is 2026-03-25.

What conditions does trial NCT06854978 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT06854978?

The interventions under investigation include: RETHA (OTHER).

Who is sponsoring clinical trial NCT06854978?

This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06854978 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06854978's enrollment target sits among peer trials

10 415th of 454 higher than 30 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

  • NCT01870752 · 10 participants · NA

    Ovarian Tissue Transplantation

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06854978, the US trial registry maintained by the National Library of Medicine. NCT06854978 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.